lvv-hemorphin-7 has been researched along with pd 123319 in 1 studies
| Studies (lvv-hemorphin-7) | Trials (lvv-hemorphin-7) | Recent Studies (post-2010) (lvv-hemorphin-7) | Studies (pd 123319) | Trials (pd 123319) | Recent Studies (post-2010) (pd 123319) |
|---|---|---|---|---|---|
| 59 | 0 | 14 | 894 | 6 | 175 |
| Protein | Taxonomy | lvv-hemorphin-7 (IC50) | pd 123319 (IC50) |
|---|---|---|---|
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.21 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.21 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.21 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebinger, G; Fournié-Zaluski, MC; Michotte, Y; Sarre, S; Stragier, B; Vanderheyden, P; Vauquelin, G | 1 |
1 other study(ies) available for lvv-hemorphin-7 and pd 123319
| Article | Year |
|---|---|
Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Hemoglobins; Imidazoles; Male; Methionine; Microdialysis; Naltrexone; Narcotic Antagonists; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonic Acids; Tetrazoles; Time Factors | 2004 |